Friedemann Honecker

6.7k total citations · 1 hit paper
119 papers, 4.2k citations indexed

About

Friedemann Honecker is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Friedemann Honecker has authored 119 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Surgery, 45 papers in Molecular Biology and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Friedemann Honecker's work include Testicular diseases and treatments (53 papers), Multiple Myeloma Research and Treatments (12 papers) and Colorectal Cancer Treatments and Studies (11 papers). Friedemann Honecker is often cited by papers focused on Testicular diseases and treatments (53 papers), Multiple Myeloma Research and Treatments (12 papers) and Colorectal Cancer Treatments and Studies (11 papers). Friedemann Honecker collaborates with scholars based in Germany, Switzerland and Netherlands. Friedemann Honecker's co-authors include Carsten Bokemeyer, Leendert H. J. Looijenga, Hans Stoop, J. Wolter Oosterhuis, Frank Mayer, Karin Oechsle, Sergey A. Dyshlovoy, Ad Gillis, Christian Kollmannsberger and Yun‐Fai Chris Lau and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Friedemann Honecker

113 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.

2003 502 citations Leendert H. J. Looijenga, Hans Stoop et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Friedemann Honecker Germany	39	2.2k	1.8k	729	612	567	119	4.2k
Ralph S. Freedman United States	43	1.5k 0.7×	847 0.5×	482 0.7×	2.0k 3.2×	1.2k 2.2×	173	5.6k
Masashi Takano Japan	38	1.8k 0.8×	839 0.5×	577 0.8×	1.2k 1.9×	2.6k 4.5×	255	5.5k
Adnan Munkarah United States	41	1.9k 0.9×	916 0.5×	566 0.8×	1.5k 2.5×	2.0k 3.5×	182	6.2k
Nobuaki Kaibara Japan	44	1.9k 0.9×	2.0k 1.1×	2.5k 3.4×	2.2k 3.6×	340 0.6×	294	6.1k
Seiji Mabuchi Japan	42	2.4k 1.1×	732 0.4×	509 0.7×	1.6k 2.7×	1.5k 2.6×	192	5.7k
Hitoshi Kohno Japan	40	1.2k 0.6×	1.5k 0.8×	846 1.2×	740 1.2×	93 0.2×	135	5.2k
Gerhard Seitz Germany	36	1.9k 0.9×	1.6k 0.9×	1.6k 2.2×	991 1.6×	82 0.1×	119	5.0k
Gaetano Facchini Italy	32	1.1k 0.5×	685 0.4×	1.2k 1.6×	1.2k 1.9×	278 0.5×	189	3.4k
E Reed United States	33	2.5k 1.1×	544 0.3×	811 1.1×	2.0k 3.2×	437 0.8×	82	4.7k
Miguel Izquierdo Spain	29	1.4k 0.6×	737 0.4×	777 1.1×	2.3k 3.8×	143 0.3×	80	3.9k

Countries citing papers authored by Friedemann Honecker

Since Specialization

Citations

This map shows the geographic impact of Friedemann Honecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friedemann Honecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friedemann Honecker more than expected).

Fields of papers citing papers by Friedemann Honecker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friedemann Honecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friedemann Honecker. The network helps show where Friedemann Honecker may publish in the future.

Co-authorship network of co-authors of Friedemann Honecker

This figure shows the co-authorship network connecting the top 25 collaborators of Friedemann Honecker. A scholar is included among the top collaborators of Friedemann Honecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friedemann Honecker. Friedemann Honecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Skowron, Margaretha A., Christoph Oing, Felix Bremmer, et al.. (2021). The developmental origin of cancers defines basic principles of cisplatin resistance. Cancer Letters. 519. 199–210. 29 indexed citations

Beyer, J., Dominik Berthold, Richard Cathomas, et al.. (2021). Swiss germ-cell cancer consensus recommendations. Swiss Medical Weekly. 151(3334). w30023–w30023. 1 indexed citations

Miranda‐Gonçalves, Vera, João Lobo, Daniela Barros‐Silva, et al.. (2021). The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors. Journal of Experimental & Clinical Cancer Research. 40(1). 268–268. 37 indexed citations

Lobo, João, Daniela Barros‐Silva, Vera Miranda‐Gonçalves, et al.. (2020). Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors. Cancers. 12(10). 2903–2903. 26 indexed citations

Honecker, Friedemann & Sergey A. Dyshlovoy. (2018). Marine Compounds and Cancer 2017. BiblioBoard Library Catalog (Open Research Library). 1 indexed citations

Honecker, Friedemann, et al.. (2018). Risk factors for unplanned discontinuation of scheduled treatment in elderly patients with castration-resistant prostate cancer: results of the IBuTu study. Journal of Cancer Research and Clinical Oncology. 144(3). 571–577. 18 indexed citations

Nastały, Paulina, Christian Ruf, Natalia Bednarz‐Knoll, et al.. (2014). Circulating Tumor Cells in Patients with Testicular Germ Cell Tumors. Clinical Cancer Research. 20(14). 3830–3841. 41 indexed citations

Oldenburg, Jan, Jorge Aparicio, J. Beyer, et al.. (2014). Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Annals of Oncology. 26(5). 833–838. 45 indexed citations

Dyshlovoy, Sergey A., Simone Venz, Larisa K. Shubina, et al.. (2013). Activity of aaptamine and two derivatives, demethyloxyaaptamine and isoaaptamine, in cisplatin-resistant germ cell cancer. Journal of Proteomics. 96. 223–239. 43 indexed citations

10.

Dyshlovoy, Sergey A., Simone Venz, Alla G. Guzii, et al.. (2013). Marine Alkaloid Monanchocidin: A Proteomic-Based Screening of Protein Targets in Cisplatin-Resistant Tumor Cells. Annals of Oncology. 24. i23–i23. 1 indexed citations

11.

Oechsle, Karin, Friedemann Honecker, Tina Cheng, et al.. (2011). Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study. Annals of Oncology. 22(12). 2654–2660. 72 indexed citations

12.

Hennigs, Jan K., Gunhild Keller, Hans Jörg Baumann, et al.. (2011). Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?. BMC Pulmonary Medicine. 11(1). 30–30. 46 indexed citations

13.

Oechsle, Karin, et al.. (2011). Treatment of patients with relapsed and/or cisplatin‐refractory metastatic germ cell tumours: an update. International Journal of Andrology. 34(4pt2). e266–73. 22 indexed citations

14.

Oechsle, Karin, Anja Lorch, Friedemann Honecker, et al.. (2010). Patterns of Relapse after Chemotherapy in Patients with High-Risk Non-Seminomatous Germ Cell Tumor. Oncology. 78(1). 47–53. 8 indexed citations

15.

Honecker, Friedemann, Hendrik Wermann, Frank Mayer, et al.. (2009). Microsatellite Instability, Mismatch Repair Deficiency, and BRAF Mutation in Treatment-Resistant Germ Cell Tumors. Journal of Clinical Oncology. 27(13). 2129–2136. 134 indexed citations

16.

Kollmannsberger, Christian, Friedemann Honecker, & Carsten Bokemeyer. (2008). Pharmacotherapy of relapsed metastatic testicular cancer. Expert Opinion on Pharmacotherapy. 9(13). 2259–2272. 16 indexed citations

17.

Bokemeyer, Carsten, Karin Oechsle, Friedemann Honecker, et al.. (2007). Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group. Annals of Oncology. 19(3). 448–453. 73 indexed citations

18.

Honecker, Friedemann. (2006). Normal and Malignant Germ Cell Development. Critical Reviews™ in Oncogenesis. 12(3-4). 297–299. 1 indexed citations

19.

Krege, S., Ch. Wittekind, Rainer Souchon, et al.. (2006). Der Hodentumor: gestern – heute – morgen. Der Urologe. 45(S04). 169–175. 1 indexed citations

20.

Cools, Martine, Friedemann Honecker, Hans Stoop, et al.. (2005). Maturation delay of germ cells in fetuses with trisomy 21 results in increased risk for the development of testicular germ cell tumors. Human Pathology. 37(1). 101–111. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact